市场调查报告书
商品编码
1577229
2030 年鱼油市场预测:按产品类型、应用和地区分類的全球分析Fish Oil Market Forecasts to 2030 - Global Analysis By Product Type (Anchovy Oil, Salmon Oil Tuna Oil, Cod Liver Oil, Sardine Oil, Menhaden Oil, Krill Oil and Other Product Types), Type, Application and By Geography |
根据Stratistics MRC预测,2024年全球鱼油市场规模将达31亿美元,预计2030年将达到46亿美元,预测期内复合年增长率为6.6%。
鱼油是从富含脂肪的鱼类组织中提取的膳食食品,富含二十二碳六烯酸 (DHA) 和二十碳五烯酸 (EPA) 等Omega-3脂肪酸。 Omega-3脂肪酸的主要益处包括降低血压和三酸甘油酯(可促进心血管健康)、促进认知能力和大脑健康,以及减少发炎(可改善关节炎等疾病)。它还具有发炎特性并支持整体健康。鱼油有液体和锭剂两种形式,是希望透过食用天然Omega-3来源来改善健康的人们的首选。
据 IFFO(海洋原料组织)称,中国是世界上最大的吴郭鱼生产国,并将这种鱼类出口到美国。
消费者对健康益处的认知不断增强
由于人们越来越重视预防性医疗保健,消费者开始转向鱼油等营养食品,作为预防关节炎和心臟病等慢性疾病的积极措施。这一趋势凸显了补充品作为健康生活的必要组成部分的重要性。此外,由于人们认识的提高,鱼油现在已包含在机能性食品中,使消费者能够在不大幅改变饮食的情况下增加Omega-3 的消费量。
与植物性Omega-3来源的竞争
有意识的消费者会被亚麻仁油和藻油等植物性替代品所吸引,它们比鱼油便宜。由于鱼油产品由于采购和製造成本而昂贵,因此市场占有率受到这种价格优势的限制。消费者对植物来源Omega-3来源的偏好正在增加,因为它们被认为是道德且永续的,这是永续性和健康趋势不断变化的结果。鱼油市场的扩张可能会受到这项变化的阻碍。
慢性病增加
由于忧郁症、关节炎和心血管疾病等长期健康问题对补充品的需求增加,补充品的销售量不断增加。鱼油作为一种预防药物越来越受欢迎,尤其是在更容易患有慢性病的老年人中。随着医疗保健转向预防,鱼油被认为是均衡饮食的重要组成部分。
污染风险
由于戴奥辛、多氯联苯和汞等毒素,消费者对鱼油补充品的不信任增加了监管机构的警觉性。 FDA 和其他健康组织就食用某些类型的鱼类时存在污染风险发出警告,因此对鱼油生产实施了更严格的监管。这种压力可能会影响製造商的成本和供应链,从而减少市场总需求。
COVID-19 大流行对鱼油市场产生了各种影响。最初,停工对供应链和生产设施造成了严重干扰,导致原材料采购和产品分销延迟。然而,随着消费者寻求增强免疫力的产品,对鱼油补充品的需求激增。这种双重效应带来了满足不断增长的需求同时克服供应限制的挑战,最终塑造了大流行期间和之后的市场动态。
预计凤尾鱼油产业在预测期内将是最大的
由于厄尔尼诺现像等环境波动对秘鲁凤尾鱼渔业造成供应问题,导致生产力下降和成本上升,预计凤尾鱼油产业将在预测期内达到顶峰。鱼油供应和市场价格受到这种稀缺的影响。然而,消费者对Omega-3脂肪酸的健康益处的认识增加了对凤尾鱼製成的产品的需求,凤尾鱼油的受欢迎程度直线上升。
Omega-3鱼油领域预计在预测期内复合年增长率最高
由于预防保健的兴起, Omega-3鱼油产业预计在预测期内将呈现最高的复合年增长率, Omega-3鱼油补充品现已成为日常生活的必需品。这种转变使得鱼油作为预防性健康措施而不是补充品变得更加重要。此外,研发活动的重点是增强Omega-3脂肪酸提取过程和采购方法的永续性,以满足不断增长的需求并解决环境问题。
由于北美水产养殖业的扩张,预计北美在预测期内将占据最大的市场占有率。这是因为水产饲料营养成分的改善取决于它。随着美国和加拿大的卫生组织提倡增加 Omega-3 脂肪酸的消费,并鼓励透过补充品和强化食品将鱼油纳入饮食中,製造商正在加强满足不同的营养需求和消费者偏好。的产品范围。
亚太地区在预测期内将呈现最高的成长率,因为该地区不断扩大的中产阶级增加了可支配收入,使他们能够在鱼油补充品等健康相关产品上花费更多。由于人口老化,特别是在日本等国家,对营养食品来管理慢性健康状况的需求也在增加。此外,永续性和道德捕捞方法正在推动消费者信心和产业扩张。
According to Stratistics MRC, the Global Fish Oil Market is accounted for $3.1 billion in 2024 and is expected to reach $4.6 billion by 2030 growing at a CAGR of 6.6% during the forecast period. Extracted from the tissues of fatty fish, fish oil is a nutritional supplement that is high in omega-3 fatty acids, including docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA). Its main benefits include lowering blood pressure and triglycerides, which promote cardiovascular health; enhancing cognitive performance and brain health; and reducing inflammation, which can help with illnesses like arthritis. Its anti-inflammatory qualities support general health. Fish oil, which is widely accessible in liquid and pill form, is a well-liked option for people looking to enhance their health by consuming natural omega-3 sources.
According to IFFO - The Marine Ingredients Organisation China is the largest producer of tilapia fish globally and exports this species to the U.S. Growing awareness about the health benefits of omega-3 in China has made the local population a prominent consumer of fish oil.
Increasing consumer awareness of the health benefits
Consumers are using dietary supplements like fish oil as proactive measures against chronic diseases like arthritis and heart disease as a result of the rising emphasis on preventive healthcare. This trend emphasizes how important supplements are as necessary elements of a healthy way of living. Furthermore, as a result of growing awareness, fish oil is now included in functional food items, enabling customers to up their omega-3 consumption without having to make major dietary changes.
Competition from plant-based omega-3 sources
Conscious customers are drawn to plant-based substitutes like flaxseed and algal oil since they are less expensive than fish oil. Because fish oil products are more expensive due to sourcing and production costs, their market share is limited by this price advantage. Growing consumer preference for plant-based omega-3 sources due to their perceived ethical and sustainable credentials is a result of shifting trends in sustainability and health. Fish oil market expansion may be hampered by this change.
Rising incidence of chronic diseases
Supplement sales are rising as a result of the growing demand for supplements brought on by long-term health issues like depression, arthritis, and cardiovascular illnesses. Fish oil is gaining popularity as a prophylactic, particularly among older populations who are more vulnerable to chronic illnesses. Fish oil is recognized as a vital part of a balanced diet as healthcare moves toward prevention.
Risk of contamination
The mistrust that consumers have for fish oil supplements as a result of toxins like dioxins, PCBs, and mercury has made regulatory agencies more vigilant. Stricter regulations for fish oil manufacturing are the result of warnings from the FDA and other health groups about the hazards of contamination when consuming specific types of fish. This pressure may have an effect on manufacturers' costs and supply chains, which may lower total market demand.
The COVID-19 pandemic has had a mixed impact on the fish oil market. Initially, it caused significant disruptions in supply chains and production facilities due to lockdowns, leading to delays in sourcing raw materials and distributing products. However, there was a surge in demand for fish oil supplements as consumers sought immune-boosting products. This dual effect has created challenges in meeting heightened demand while navigating supply constraints, ultimately shaping the market dynamics during and after the pandemic
The anchovy oil segment is expected to be the largest during the forecast period
The anchovy oil segment is expected to be the largest during the forecast period owing to environmental variables such as El Nino have caused supply issues for the Peruvian anchovy fishery, leading to decreased productivity and higher costs. Fish oil supply and market prices are impacted by this scarcity. However, the demand for products based on anchovies has increased due to consumer awareness of the health advantages of omega-3 fatty acids, which has led to a surge in the popularity of anchovy oil.
The omega-3 fish oil segment is expected to have the highest CAGR during the forecast period
The omega-3 fish oil segment is expected to have the highest CAGR during the forecast period due to the increase in preventive healthcare, and omega-3 fish oil supplements are now a necessary part of everyday life. This change emphasizes fish oil as a preventative health measure as opposed to a supplement. Additionally research and development activities are focused on enhancing extraction procedures and sustainability of sourcing practices for omega-3 fatty acids to fulfill growing demand and solve environmental concerns.
North America is expected to have the largest market share over the projection period due to the expanding aquaculture sector in North America. This is because improved aquafeed nutritional profiles depend on it. Health groups in the US and Canada are pushing for increased consumption of omega-3 fatty acids and urging people to include fish oil in their diets by way of supplements and foods that have been fortified thus to accommodate varying dietary requirements and consumer preferences, manufacturers are expanding the range of products they offer.
Asia Pacific is anticipated to witness the highest rate of growth during the forecast period due to higher disposable earnings brought about by the expanding middle class in Asia-Pacific nations enable customers to spend more on health-related goods like fish oil supplements. The need for nutritional supplements to manage chronic health disorders is also being driven by the aging population, especially in nations such as Japan. Additionally enhancing consumer confidence and driving industry expansion are sustainability initiatives and ethical fishing methods.
Key players in the market
Some of the key players in Fish Oil Market include Croda International plc, Ocean Group Ltd, GC Rieber, BASF SE, DSM, Sursan, Omega Protein Corporation, TripleNine, OLVEA Group, Pesquera Exalmar, Marvesa Holding N.V., Colpex International, Copeinca AS, FMC Corporation and Corpesca S.A.
In October 2024, BASF has introduced its new Emulgade(R) Verde line of natural-based emulsifiers for personal care at the SEPAWA Congress 2024. This innovative product line focuses on sustainable, naturally derived emulsifiers that are non-ethoxylated and suitable for a variety of applications.
In May 2024, DSM and Firmenich announced that they have entered into a business combination agreement (the "BCA") to establish the leading creation and innovation partner in nutrition, beauty and well-being ("DSM-Firmenich").